← Back to Search

Other

Avocado Mango for Pre-diabetes (AVMa Trial)

N/A
Waitlist Available
Led By Britt Burton-Freeman, Ph.D
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline-8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if eating one avocado and one mango daily can help people with prediabetes by improving their blood vessel health, cognitive function, and kidney function. Mangos have shown antidiabetic, anti-inflammatory, and heart-protective properties.

Who is the study for?
This trial is for men and women aged 25-70 with prediabetes, having fasting blood glucose levels between 100-125 mg/dL. Participants should be in good health without major diseases or recent surgeries that could affect the study's results. They shouldn't take medications or supplements that might interfere with outcomes, must not abuse substances, and non-smokers are preferred.
What is being tested?
The study tests how eating avocados and mangos affects vascular function over 8 weeks compared to a control diet. It measures changes in artery flexibility, blood pressure, eye vessel health using OCTA technology, cognitive performance through specific tasks, and kidney function indicators.
What are the potential side effects?
While the trial does not focus on side effects of avocado and mango consumption directly, potential side effects may include digestive discomfort or food-related allergies for those sensitive to these fruits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline-8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline-8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in Central Blood pressure
Changes in Kidney function markers
Changes in Pulse Wave Velocity
+9 more
Secondary study objectives
Changes in Cognitive Function
Changes in Cognitive Function-1
Changes in Cognitive Function-2
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Control meal planExperimental Treatment1 Intervention
2 meals and snacks per day, without avocado and mango, covering 75% of daily calories needs
Group II: Avocado mango meal planExperimental Treatment1 Intervention
2 meals and snacks per day, including 1 avocado + 1 cup of mango, covering 75% of daily calories needs,

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for prediabetes often include dietary interventions that focus on the intake of bioactive compounds such as antioxidants, vitamins, and healthy fats. These compounds can improve insulin sensitivity, reduce oxidative stress, and enhance vascular function. For example, antioxidants help neutralize free radicals, reducing inflammation and oxidative damage to cells, which is crucial for maintaining healthy blood sugar levels. Vitamins, particularly those with anti-inflammatory properties, support metabolic processes and improve insulin function. Healthy fats, such as those found in avocados, can improve lipid profiles and reduce insulin resistance. These mechanisms are vital for prediabetes patients as they help prevent the progression to type 2 diabetes and reduce the risk of associated cardiovascular complications.
Natural Products Derived from the Mediterranean Diet with Antidiabetic Activity: from Insulin Mimetic Hypoglycemic to Nutriepigenetic Modulator Compounds.

Find a Location

Who is running the clinical trial?

Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
54 Previous Clinical Trials
2,920 Total Patients Enrolled
Hass Avocado BoardOTHER
12 Previous Clinical Trials
681 Total Patients Enrolled
National Mango BoardOTHER
6 Previous Clinical Trials
221 Total Patients Enrolled
Britt Burton-Freeman, Ph.DPrincipal InvestigatorIllinois Institute of Technology
28 Previous Clinical Trials
1,705 Total Patients Enrolled

Media Library

Avocado mango (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05353790 — N/A
Prediabetes Research Study Groups: Avocado mango meal plan, Control meal plan
Prediabetes Clinical Trial 2023: Avocado mango Highlights & Side Effects. Trial Name: NCT05353790 — N/A
Avocado mango (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05353790 — N/A
~19 spots leftby Dec 2025